Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (661-670 of 716) with videos related to

Pageof 72
Sort By:
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
International Journal of Laboratory Hematology|August 12, 2008
Rule based processing of the CD4000, CD3200 and CD Sapphire analyser output using the Cerner Discern Expert ModuleP Burgess, H Robin, M Langshaw, et al.
BMJ (Clinical Research Ed.)|March 25, 2025
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
Journal of Clinical Pharmacology|July 6, 2025
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse EffectsJessica Chadwick, Colin Berry, Meredith A Carpenter, et al.
Bioorganic & Medicinal Chemistry|September 9, 2021
Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2Wan-Chen Tsai, Nathan C Gilbert, Amanda Ohler, et al.
Journal of Medicinal Chemistry|January 8, 2014
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseDiane K Luci, J Brian Jameson, Adam Yasgar, et al.
The New England Journal of Medicine|September 15, 2017
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R Holman, M Angelyn Bethel, Robert J Mentz, et al.
JCI Insight|July 2, 2026
A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in DiabetesKristin M Corey, Maggie Nguyen, Michael Y Mi, et al.
Diabetes Care|October 8, 2017
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS TrialAbhinav Sharma, Jennifer B Green, Allison Dunning, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2022
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Pageof 72

Showing results (661-670 of 716) with videos related to

Sort By:
Pageof 72
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
International Journal of Laboratory Hematology|August 12, 2008
Rule based processing of the CD4000, CD3200 and CD Sapphire analyser output using the Cerner Discern Expert ModuleP Burgess, H Robin, M Langshaw, et al.
BMJ (Clinical Research Ed.)|March 25, 2025
Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
Journal of Clinical Pharmacology|July 6, 2025
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse EffectsJessica Chadwick, Colin Berry, Meredith A Carpenter, et al.
Bioorganic & Medicinal Chemistry|September 9, 2021
Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2Wan-Chen Tsai, Nathan C Gilbert, Amanda Ohler, et al.
Journal of Medicinal Chemistry|January 8, 2014
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseDiane K Luci, J Brian Jameson, Adam Yasgar, et al.
The New England Journal of Medicine|September 15, 2017
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R Holman, M Angelyn Bethel, Robert J Mentz, et al.
JCI Insight|July 2, 2026
A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in DiabetesKristin M Corey, Maggie Nguyen, Michael Y Mi, et al.
Diabetes Care|October 8, 2017
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS TrialAbhinav Sharma, Jennifer B Green, Allison Dunning, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2022
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Pageof 72